ES2111083T3 - Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). - Google Patents
Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).Info
- Publication number
- ES2111083T3 ES2111083T3 ES92920802T ES92920802T ES2111083T3 ES 2111083 T3 ES2111083 T3 ES 2111083T3 ES 92920802 T ES92920802 T ES 92920802T ES 92920802 T ES92920802 T ES 92920802T ES 2111083 T3 ES2111083 T3 ES 2111083T3
- Authority
- ES
- Spain
- Prior art keywords
- compositions containing
- quinolones
- stirene
- sulphonate
- antibiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE DESCRIBEN COMPOSICIONES FARMACEUTICAS ACUOSAS CONTENIENDO UNA COMBINACION SINERGICA DE UNA QUINOLONA Y UN POLIMERO ACIDO SULFONICO DE POLIESTIRENO, DONDE LAS COMPOSICIONES SON SOLUCIONES LIMPIAS QUE RESULTAN CONFORTABLES Y TIENEN LIBERACION SOSTENIDA. SE DESCRIBEN METODOS PARA USO DE LAS COMPOSICIONES. ESTE TIPO DE FORMULACION ES PARTICULARMENTE UTIL CON QUINOLONAS DEL TIPO DE CIPROFLOXACINA, AUMENTANDO CONSIDERABLEMENTE LA SOLUBILIDAD DE ESTAS QUINOLONAS, HACIENDO FACTIBLE PODER TENER SOLUCIONES ACUOSAS QUE CONTIENEN TALES QUINOLONAS EN, O CERCA DE, PH FISIOLOGICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76110491A | 1991-09-17 | 1991-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2111083T3 true ES2111083T3 (es) | 1998-03-01 |
Family
ID=25061139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92920802T Expired - Lifetime ES2111083T3 (es) | 1991-09-17 | 1992-09-11 | Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). |
Country Status (9)
Country | Link |
---|---|
US (1) | US5679336A (es) |
EP (1) | EP0604570B1 (es) |
AT (1) | ATE162081T1 (es) |
AU (1) | AU2672892A (es) |
DE (1) | DE69224071T2 (es) |
DK (1) | DK0604570T3 (es) |
ES (1) | ES2111083T3 (es) |
GR (1) | GR3026209T3 (es) |
WO (1) | WO1993005816A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2106680B1 (es) * | 1995-08-03 | 1998-07-01 | Vita Invest Sa | Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes. |
US5695882A (en) * | 1995-08-17 | 1997-12-09 | The University Of Montana | System for extracting soluble heavy metals from liquid solutions |
ID21415A (id) | 1997-12-05 | 1999-06-10 | Upjohn Co | Senyawa-senyawa antibiotik magnesium quinolon |
US6290946B1 (en) | 1999-05-13 | 2001-09-18 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders and antibacterial agents |
EP1800687A3 (en) * | 1999-05-13 | 2009-12-30 | Genzyme Corporation | Anionic polymers as toxin binders and antibacterial agents |
US6270755B1 (en) * | 1999-05-13 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders |
US6514492B1 (en) | 1999-07-14 | 2003-02-04 | Schering-Plough Veterinary Corporation | Taste masking of oral quinolone liquid preparations using ion exchange resins |
SI1200129T1 (sl) * | 1999-07-14 | 2009-06-30 | Schering Plough Ltd | maskiranje okusa oralnih kinolonskih tekočih pripravkov z uporabo ionskih izmenjevalnih smol |
AU776609B2 (en) | 1999-09-24 | 2004-09-16 | Novartis Ag | Topical suspension formulations containing ciprofloxacin and dexamethasone |
CA2386822A1 (en) | 1999-11-01 | 2001-05-10 | Alcon, Inc. | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
CA2314494A1 (en) | 2000-05-02 | 2001-11-02 | Geltex Pharmaceuticals, Inc. | Anionic polymers as species specific antibacterial agents |
PL199321B1 (pl) | 2000-07-28 | 2008-09-30 | Alcon Inc | Kompozycje farmaceutyczne zawierające tobramycynę i gumę ksantanową |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
EP1429780B1 (en) | 2001-09-21 | 2005-12-21 | Alcon, Inc. | Method of treating middle ear infections |
JP2006151808A (ja) * | 2002-12-24 | 2006-06-15 | Dai Ichi Seiyaku Co Ltd | 抗菌性水性製剤 |
DE102006010643A1 (de) * | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
US20100209538A1 (en) * | 2009-02-18 | 2010-08-19 | Cipolla David C | Ph-modulated formulations for pulmonary delivery |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53141286A (en) * | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
CA1175836A (en) * | 1977-09-20 | 1984-10-09 | Marcel Pesson | Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives |
JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
US4615882A (en) * | 1982-09-27 | 1986-10-07 | Stockel Richard F | Disinfectant solution for contact lens |
DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
-
1992
- 1992-09-11 DE DE69224071T patent/DE69224071T2/de not_active Expired - Fee Related
- 1992-09-11 AT AT92920802T patent/ATE162081T1/de not_active IP Right Cessation
- 1992-09-11 DK DK92920802T patent/DK0604570T3/da active
- 1992-09-11 WO PCT/US1992/007744 patent/WO1993005816A1/en active IP Right Grant
- 1992-09-11 EP EP92920802A patent/EP0604570B1/en not_active Expired - Lifetime
- 1992-09-11 AU AU26728/92A patent/AU2672892A/en not_active Abandoned
- 1992-09-11 ES ES92920802T patent/ES2111083T3/es not_active Expired - Lifetime
-
1995
- 1995-10-18 US US08/544,624 patent/US5679336A/en not_active Expired - Fee Related
-
1998
- 1998-02-25 GR GR980400386T patent/GR3026209T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE162081T1 (de) | 1998-01-15 |
EP0604570A1 (en) | 1994-07-06 |
GR3026209T3 (en) | 1998-05-29 |
EP0604570B1 (en) | 1998-01-14 |
DE69224071D1 (de) | 1998-02-19 |
DE69224071T2 (de) | 1998-05-07 |
WO1993005816A1 (en) | 1993-04-01 |
US5679336A (en) | 1997-10-21 |
AU2672892A (en) | 1993-04-27 |
DK0604570T3 (da) | 1998-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2111083T3 (es) | Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). | |
DK354785D0 (da) | Stabile salte af s-adenosyl-l-methionin med polyanioner | |
ATE376423T1 (de) | Gelierende wässrige pharmazeutische zusammensetzungen | |
BR0208741A (pt) | Derivados de piperidina | |
DK0539204T3 (da) | Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre | |
TR200302242T2 (tr) | Protein kinaz önleyicileri olarak pirolopirimidinler | |
ES2097174T3 (es) | Derivados de la 2-ciclohexan-1-il amina. | |
DE69908819D1 (de) | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten | |
NO970051L (no) | Vandige risperidon formuleringer | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
ATE526022T1 (de) | Stabilisierte zusammenstellungen die benzimidazole enthalten | |
CA2447924A1 (en) | Olopatadine formulations for topical administration | |
BR0005915A (pt) | Comprimido matriz que possibilita a liberação prolongada de trimetazidina após a administração pela via oral | |
DK0866791T3 (da) | Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
ATE259813T1 (de) | Triazolopyrimidinderivate | |
MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
DK1102594T3 (da) | Anvendelse af natriumchlorid til nedsættelse af den gastrointestinale toxicitet af derivater af camptothecin | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
DE69828390D1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
PT99091A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados da triazina e da pirimidina, como ingredientes activos, destinadas a reverter a resistencia aos agentes anticancerosos e antimalaricos | |
ATE241640T1 (de) | Fusidinsäure-derivate | |
NO940064L (no) | Öyepreparat på polyakrylsyrebasis | |
DE60039782D1 (de) | Amidinophenylbrenztraubensäure-derivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 604570 Country of ref document: ES |